Action DRREDDY DR. REDDY'S LABORATORIES LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Dr. Reddy's Laboratories Limited

Actions

DRREDDY

INE089A01023

Marché Fermé - Bombay S.E.
Autres places de cotation
 12:00:50 26/04/2024 		Varia. 5j. Varia. 1 janv.
6 253 INR +0,58% Graphique intraday de Dr. Reddy's Laboratories Limited +5,23% +7,85%
26/04 Les actions asiatiques négociées aux États-Unis sous forme de certificats de dépôt américains sont en hausse vendredi et terminent la semaine en hausse de 3,5%. MT
25/04 Les valeurs technologiques en tête des actions asiatiques échangées aux Etats-Unis en tant que American Depositary Receipts en baisse dans les échanges de jeudi MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.5%
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading
Nestle India Reports Rise in Quarterly Profit, Announces JV With Dr. Reddy's Laboratories
Banking Stocks Lift Indian Equities Higher
Dr. Reddy's Laboratories Names CEO-North America
Dr. Reddy's Laboratories Limited Announces Executive Changes
Dr. Reddy's Laboratories Limited and Nestle India Limited Enter into Joint Venture Agreement for Investment in Dr. Reddy's Nutraceuticals Limited
Genentech And Dr. Reddy's Settle BPCIA Rituximab Litigation
Dr. Reddy's Laboratories Recalls Sapropterin Dihydrochloride Oral Solution Powder in US
Dr. Reddy's Laboratories Recalls Sapropterin Dihydrochloride Powder Over Potency Concerns
Dr Reddy Laboratories : . Reddy’s issues voluntary nationwide recall of Sapropterin Dihyochloride Powder for Oral Solution 100 mg due to Sub-potency - Form 6-K
Technology Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading
Dr Reddy Laboratories : Corporate_Governance_Report- March 31_2024
Dr Reddy Laboratories : . Reddy's launches Condition Management programme ‘DailyBloom™ IBS’, India’s first-ever digital integrated care plan to manage Irritable Bowel Synome - Form 6-K
Dr. Reddy's Labortories Launches Care Plan for IBS Patients
India's Biocon developing its own version of Wegovy, clinical trial likely next year
Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
Dr. Reddy's Laboratories Limited Receives an Order from the Commissioner of CGST,, Chandigarh
Asian Equities Traded in the US as American Depositary Receipts Remain Flat in Wednesday Trading
Financial, Telecoms Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Sharply Lower Tuesday
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action DRREDDY
  4. Actualités Dr. Reddy's Laboratories Limited
  5. Autres langues